Comparison of the pharmacokinetics of diazepam after single and subchronic doses
- 1 January 1976
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 10 (2), 121-126
- https://doi.org/10.1007/bf00609470
Abstract
In seven healthy male volunteers the effects of the pattern of dosing on the pharmacokinetics of diazepam have been studied. A cross-over design was employed that consisted of three parts: a single intravenous dose (0.1 mg/kg), and oral dosing (10 mg/day) for six days followed by an intravenous bolus (0.1 mg/kg) on the seventh day, followed by re-examination of a single intravenous dose after diazepam (D) and its major metabolite desmethyldiazepam (DD) had been completely eliminated. Plasma levels of D and DD were monitored by a specific, sensitive GLC-method. In younger patients (n=5, age 29 – 35 years) the elimination half-life, T1/2 (β), of D was 33.9±10.6 h (mean±S.D.) after the single dose. The control study gave an almost identical result (35.7±12.1). After subchronic dosage in all patients T1/2 (β) showed a modest but significant prolongation (paired t-test p<0.01) to 52.9±17.4 h. It was caused by a significant decrease (p=0.016) in total plasma clearance ( \(\overline {\user1{Cl}} \) ), from 26.0±10.8 ml/min to 18.2±7.0 ml/min. Older patients (age 43–60 years) showed the same phenomenon. Blood/plasma ratios remained constant indicating no change in protein binding. Biliary excretion of D was measured in five patients with a T-tube. Only negligible amounts (0.3–0.4%) of administered D were excreted within 3 days after subchronic dosage, which demonstrates a lack of enterohepatic cycling of D. After multiple administration of D, there was accumulation of DD to levels approximately five times higher than after a single dose. The possibility that the slower elimination of D after subchronic treatment might be caused by DD was also supported by experiments in dogs and rabbits. After pretreating rabbits with DD and maintaining a high DD plasma level, there was prolongation of T1/2 (β) from 2.7 h to 5.2 h, with a corresponding decrease of \(\overline {\user1{Cl}} \) from 101.6 ml/min to 23.4 ml/min. Similar results were obtained in dogs. It is concluded that the disposition of D is altered by subchronic use and may be regulated by the plasma DD concentration.
Keywords
This publication has 18 references indexed in Scilit:
- The effects of age and liver disease on the disposition and elimination of diazepam in adult man.Journal of Clinical Investigation, 1975
- Methaqualone pharmacokinetics after single- and multiple-dose administration in manJournal of Pharmacokinetics and Biopharmaceutics, 1974
- Pharmacokinetic Profile of Diazepam in Man following Single Intravenous and Oral and Chronic Oral AdministrationsJournal of Pharmaceutical Sciences, 1973
- Interactions of Benzodiazepines with WarfarinBMJ, 1972
- Effects of Change in Elimination on Various Parameters of the Two-Compartment Open ModelJournal of Pharmaceutical Sciences, 1972
- PHARMACOKINETICS OF DISTRIBUTION AND METABOLISM OF ATARACTIC DRUGS AND AN EVALUATION OF THE SITE OF ANTIANXIETY ACTIVITY*Annals of the New York Academy of Sciences, 1971
- Pharmacokinetics of Diazepam in Dogs, Mice and HumansActa Pharmacologica et Toxicologica, 1971
- The metabolism of diazepam by liver microsomal enzymes of rats and miceEuropean Journal of Pharmacology, 1969
- Shortcomings in Pharmacokinetic Analysis by Conceiving the Body to Exhibit Properties of a Single CompartmentJournal of Pharmaceutical Sciences, 1968
- Blood Level Distribution Patterns of Diazepam and its Major Metabolite in ManJournal of Pharmaceutical Sciences, 1966